Securities fraud class actions against life sciences companies increased by 65 percent in 2012 compared to 2011, reversing a previous dip, according to a new Dechert report.
Source: http://www.law.com/jsp/nlj/PubArticleNLJ.jsp?id=1202593063394&rss=rss_nlj
personal injury lawyer personal injury lawyers
No comments:
Post a Comment